Chargement en cours...
SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
Background: Obese Type 2 diabetes(T2DM) patients with high insulin resistance may require insulin U500 therapy. There is a lack of safety and efficacy data for the use of Pramlintide (P) as an adjunct therapy with U500 insulin (U500I) to maintain optimal glucose control and effect on daily insulin r...
Enregistré dans:
| Publié dans: | J Endocr Soc |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Endocrine Society
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552323/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB028 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|